|

SKB571 for injection Clinical Trials

4 actively recruiting trials

▲ +2 trials since August 2026

Pipeline

Phase 2: 4

Top Sponsors

  • Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.4

Indications

  • Cancer4
  • Lung Cancer3
  • Non Small Lung Cancer1
  • Lung Cancer - Non Small Cell1
  • Gastrointestinal Tumors1

Other4 trials

A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities
Phase 2
A Phase II Study of SKB571 in Patients With Lung Cancer
Phase 2
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
Phase 2
A Study of SKB571 in Participants With Gastrointestinal Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.